Tender detail
Non-exclusive discount agreements for aflibercept medicines under an open-house model
Summary
The procurement concerns non-exclusive discount agreements for medicines containing aflibercept as an injection solution in a vial (ATC code S01LA05), excluding the 114.3 mg/ml strength. Agreements are concluded through an open-house model, with no guaranteed minimum purchase quantity; demand is unknown. Agreements end no later than 31 December 2027.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.